Edwards Lifesciences (EW) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences (EW) PT Lowered to $118 at Barclays on 3Q; 'Quarter Over Quarter Slowdown in U.S. TAVR Growth'
October 25, 2017 12:36 PM EDTBarclays lowered its price target on Edwards Lifesciences (NYSE: EW) to $118.00 (from $120.00) while maintaining a Equalweight rating, following the company's third quarter earnings report.
Analyst Matthew Taylor notes the company delivered third quarter earnings per share and revenue results below consensus projections, as... More
Edwards Lifesciences (EW) PT Lowered to $135 at Canaccord Genuity
October 25, 2017 5:33 AM EDTCanaccord Genuity lowered its price target on Edwards Lifesciences (NYSE: EW) to $135.00 (from $155.00) while maintaining a Buy rating.
Analyst Jason Mills remains positive on the stock noting LT TAVR & TMVR catalyst trump the negative NT trends and would be a buyer on weakness in the $100 range.
... More